« Personal Injury Roundup No. 74 | Main | Guest Blogger Andrew Klein: "Science, Causation, and Toxic Torts" »
April 25, 2010
IOM to Advise FDA on Post-Marketing Drug Safety Trials
The Institute of Medicine has been called upon to advise the FDA regarding post-marketing drug safety trials. George Conk at Otherwise has the details.
--CJR
April 25, 2010 in Current Affairs, Experts & Science | Permalink
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341bfae553ef0133ecf1ead2970b
Listed below are links to weblogs that reference IOM to Advise FDA on Post-Marketing Drug Safety Trials:
